WallStreetZenWallStreetZen

NASDAQ: VERA
Vera Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

VERA earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$96.0M
Current Profit Margin
0%

VERA Return on Equity

Current Company
-73.3%
Current Industry
-63.5%
Current Market
188%
VERA's Return on Equity (-73.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when VERA announces earnings.

VERA Return on Assets

Current Company
-50.8%
Current Industry
2.9%
VERA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

VERA Return on Capital Employed

Current Company
-60.17%
Current Industry
19.5%
VERA has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VERA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
VERA$0.00-$94.07M-$95.99MN/AN/A
KYMR$78.59M-$143.20M-$146.96M+127.50%N/A
CLDX$6.88M-$138.42M-$141.43M-6.32%N/A
TGTX$233.66M$25.89M$12.67M+333.86%N/A
RCKT$0.00-$236.62M-$245.60MN/AN/A
View Top Biotech Stocks

VERA earnings dates

Next earnings date
May 9, 2024

Vera Therapeutics Earnings & Revenue FAQ

What were VERA's earnings last quarter?

On Invalid Date, Vera Therapeutics (NASDAQ: VERA) reported Q4 2023 earnings per share (EPS) of -$0.58, up 51.26% year over year. Total Vera Therapeutics earnings for the quarter were -$25.66 million. In the same quarter last year, Vera Therapeutics's earnings per share (EPS) was -$1.19.

If you're new to stock investing, here's how to buy Vera Therapeutics stock.

What was VERA's earnings growth in the past year?

As of Q2 2024, Vera Therapeutics's earnings has grown year over year. Vera Therapeutics's earnings in the past year totalled -$95.99 million.

What is VERA's earnings date?

Vera Therapeutics's earnings date is Invalid Date. Add VERA to your watchlist to be reminded of VERA's next earnings announcement.

What was VERA's revenue last quarter?

On Invalid Date, Vera Therapeutics (NASDAQ: VERA) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Vera Therapeutics's revenue was $0.00.

What was VERA's revenue growth in the past year?

As of Q2 2024, Vera Therapeutics's revenue has grown null year over year. Vera Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.